Preclinical models of Parkinson's disease (PD) have been developed using intracerebroventricular (i.c.v.) injection of 6-hydroxydopamine (6-OHDA) to induce neurodegeneration and motor dysfunction.

Ionis and Ultragenyx are competing to develop oligonucleotide treatments for Angelman syndrome, but will Neuren’s peptide ...

A child with a rare genetic disorder — spinal muscular atrophy type I — was treated prenatally for the first time. Courtesy of Jakob Owens  via Unsplash During an amniocentesis test, a long, thin ...

The White House said it followed the court’s written ruling. The judge verbally instructed planes en route to turn around.

Despite a judge's order barring the Trump administration from carrying out its planned deportations—and an admonition to have ...

A Fairview Elementary School parent has been charged with communicating a threat of mass violence on educational property ...

A new study provides strong evidence that bacterial vaginosis, a common vaginal condition, is spread during sex. But experts ...

Pfizer has terminated a Phase I trial of its investigational STING therapy in advanced solid tumors, according to an update ...

A vaccine against norovirus, the dreaded “winter vomiting bug”, could be closer than you think: early clinical trials have ...

Leading UCSF physician-scientists are developing targeted treatments, earlier diagnostics, and helping to solve tuberculosis’ ...

Part B covers medical care that you receive in a hospital outpatient setting such as an ER, outpatient surgery center or pain ...

A research group, led by Dr. Pavel Majer from IOCB Prague, in collaboration with the laboratories of Barbara Slusher and ...